A jury found McKesson and Cencora liable for $266 million in damages to the city of Baltimore for fueling the opioid crisis.

Leading medical distributors McKesson (NYSE:MCK) and Cencora (NYSE:COR) will have to pay $266M in damages to Baltimore after ...

McKesson Corporation's ( NYSE:MCK ) stock was strong despite it releasing a soft earnings report last week. Our... The city ...

The city of Baltimore won $266 million in its lawsuit accusing top drug distributors McKesson and Cencora of fueling an ...

McKesson Medical-Surgical Inc. entered into an agreement with the Labor Department on Monday resolving employment ...

Drug distributor McKesson Corp raised its annual profit forecast on Wednesday, driven by increased sales in its U.S.

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch ...

Susman Godfrey partner Bill Carmody said the $266 million “verdict was an important step toward helping Baltimore recover so ...

Jurors found that the companies, McKesson and AmerisourceBergen, unreasonably shipped huge sums of painkillers to the ...

The US Food and Drug Administration (FDA) has approved Azurity Pharmaceuticals’ Danziten (nilotinib), the first and only ...

Revenue: US$93.7b (up 21% from 2Q 2024). Net income: US$241.0m (down 64% from 2Q 2024). Profit margin: 0.3% (down from 0.9% ...

A Baltimore jury found two drug distributors liable for contributing to the city's ongoing opioid crisis. The decision came ...